Greenwich LifeSciences, Inc.
GLSI· Nasdaq
Released Mar 31, 2021, after the close
10-K filed Mar 31, 2021, 90 days after period end · 0001493152-21-007532
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|
| Net Income | -$1.15M | -$336.54K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 31, 2021 · 90 d after period end
+1.8% from the close of Mar 31, 2021 to the close of Apr 1, 2021, the first after the release.